Covered recipient · General Payments record
DEBORAH ANUGWOM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$760.75
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.18 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $151.14 | 3 |
| ABBVIE INC. | $30.14 | 1 |
| Acerta Pharma LLC | $29.85 | 2 |
| Otsuka America Pharmaceutical, Inc. | $21.05 | 1 |
| Currax Pharmaceuticals LLC | $16.35 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.37 | 1 |
| DEXCOM, INC. | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.14 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103232301 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123308734 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.40 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123310336 | CMS |
| Currax Pharmaceuticals LLC | $16.35 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089520996 | CMS |
| Dexcom, Inc. | $13.28 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153357321 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.37 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146781366 | CMS |
| Lilly USA, LLC | $18.87 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135613924 | CMS |
| Lilly USA, LLC | $119.74 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135567670 | CMS |
| Lilly USA, LLC | $12.53 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135633976 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.05 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119016946 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.